SECsense Logo

Zimmer Biomet Holdings, Inc. 8-K Report: Debt Management Insights & Financial Overview

$ZBH
Form 8-K
Filed on: 2025-02-19
Source
Zimmer Biomet Holdings, Inc. 8-K Report: Debt Management Insights & Financial Overview

Here is a summary of the key insights extracted from the provided financial report section:

  1. Entity Information:
  • Company Name: Zimmer Biomet Holdings, Inc.
  • CIK Identifier: 0001136869
  • Address: 345 East Main Street, Warsaw, IN 46580
  • Phone: (574) 373-3333
  • Stock Exchange: NYSE
  1. Securities Information:
  • Common Stock: Par value of $0.01
  • Notes Issued:
    • 2.425% Notes due 2026
    • 1.164% Notes due 2027
    • 3.518% Notes due 2032
  1. Filing Type: Form 8-K
  2. Report Date: February 19, 2025
  3. XBRL Context:
  • The report uses XBRL (eXtensible Business Reporting Language) to structure its financial data, indicating compliance with SEC reporting standards.
  1. Segments Identified:
  • The document identifies several segments related to different classes of stock and debt instruments, specifically noting various notes due in different years.
  1. Financial Reporting Period:
  • The reporting period is a single day: February 19, 2025.

Insights:

  • The company is actively managing its debt with multiple notes that have varying maturity dates and interest rates, which may indicate a strategic approach to financing and cash flow management.
  • The presence of different classes of stock and debt securities suggests a potentially diverse capital structure that could impact investor interest and financial analysis.
  • Being listed on the NYSE with publicly traded securities might provide liquidity and market visibility for the company.

This information can be valuable for investors, analysts, and stakeholders to assess the company's financial health, capital structure, and future obligations.